What’s trending in pharmacovigilance? New podcast episode

Perspective / 21 December 2023

In this festive edition of Drug Safety Matters, we wrap up the year that was and look ahead to the year that will be – with a little help from one of our friends.


WHAT DID THE DRUG SAFETY COMMUNITY ACHIEVE IN 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro, president of the International Society of Pharmacovigilance, to walk us through current and future trends in pharmacovigilance.

Among her predictions, hear her thoughts on patient engagement – a hot topic that is going to get hotter – as well as the challenges she foresees closest to home in Latin America.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

Related Articles

Patient perspectives in PV at the ISoP Mid-Year Symposium – New podcast episode

Linking Pharmacogenomics and Pharmacovigilance Data to Solve Drug-induced Problems

How can the ‘Black Swan Theory’ help us Prevent Adverse Drug Reactions?

You may also like

Linking Pharmacogenomics and Pharmacovigilance Data to Solve Drug-induced Problems

Pharmacovigilance has come a long way in helping us link medicines to their side-effects; with the help of pharmacogenomics it can go even further.

05 February 2025

How can the ‘Black Swan Theory’ help us Prevent Adverse Drug Reactions?

How does an economics theory apply to drug safety, and how can we use it to better manage rare, unexpected, and serious adverse drug reactions?

23 September 2024

Patient perspectives in PV at the ISoP Mid-Year Symposium – New podcast episode

Patient engagement was a hot topic at the fireside chat held during this year’s ISoP mid-year symposium.

24 June 2025